Clinical-stage biotechnology company Eyestem Research has raised $10 million in a Series B funding round co- led by Raju Barwale and Alkem Laboratories managing director Sandeep Singh.
The Bengaluru-based company had previously raised $9.95 million from Alkem Lab., Biological E and C-CAMP.
The proceeds will be utilized for the completion of the ongoing Phase 2 clinical trial in India and support preparations for filing an…








